Structure and function of cobra venom factor, the complement-activating protein in cobra venom

Advances in Experimental Medicine and Biology

Volumn 391, Issue , 1996, Pages 97-114

  Vogel, Carl Wilhelm ^a   Bredehorst, Reinhard ^a   Fritzinger, David C ^b   Grunwald, Thomas ^a   Ziegelmüller, Patrick ^a   Kock, Michael A ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b SRA Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBROTOXIN; COMPLEMENT MEMBRANE ATTACK COMPLEX;

ARTICLE; COMPLEMENT ACTIVATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; SNAKEBITE;

EID: 0029993188     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0361-9_6     Document Type: Article

References (47)

1. C.-W. Vogel: Cobra venom factor, the complement-activating protein of cobra venom. In Handbook of Natural Toxins. Vol. 5, Peptile and Amphibian Venoms. A. T. Tu, ed. Marcel Dekker, New York 1991, 147-188.
2. H. J. Müller-Eberhard. Molecular organization and function of the complement system. 1988. Ann. Rev. Biochem. 57, 321-347.
3. T. Kinoshita. Biology of complement: the overture. 1991. Immunology Today 12, 291-295.
4. B. P. Morgan, and M. J. Walport. Complement deficiency and disease. 1991. Immunology Today 12, 301-306.
5. G. Eggertsen, P. Lind, and J. Sjöquist: Molecular characterization of the complement activating protein in the venom of the Indian cobra (Naja n. siamensis). 1981. Mol. Immunol. 18, 125-133.
6. C.-W. Vogel, and H. J. Müller-Eberhard: Cobra venom factor: Improved method for purification and biochemical characterization. 1984. J. Immunol. Meth. 73, 203-220.
7. C.-W. Vogel, C. A. Smith, and H. J. Müller-Eberhard: Cobra venom factor: Structural homology with the third component of human complement. 1984. J. Immunol. 133, 3235-3241.
8. C. A. Smith, C.-W. Vogel, and H. J. Müller-Eberhard: Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement. 1982. J. Biol. Chem. 257, 9879-9882.
9. A. H. Grier, M. Schultz, and C.-W. Vogel: Cobra venom factor and human C3 share carbohydrate antigenic determinants. 1987. J Immunol. 139, 1245-1252.
10. D. C. Gowda, M. Schultz, R. Bredehorst, and C.-W. Vogel: Structure of the major oligosaccharide of cobra venom factor. 1992. Mol. Immunol. 29, 335-342.
11. D. C. Gowda, E. C. Petrella, T. T. Raj, R. Bredehorst, and C.-W. Vogel: Immunoreactivity and function of oligosaccharides in cobra venom factor. 1994. J. Immunol. 152, 2977-2986.
12. H. J. Müller-Eberhard, and K.-E. Fjellström: Isolation of the anticomplementary protein from cobra venom and its mode of action on C3. 1971. J. Immunol. 107, 1666-1672.
13. W. Vogt, L. Dieminger, R. Lynen, and G. Schmidt: Alternative pathway tor the activation of complement in human serum. Formation and composition of the complex with cobra venom factor that cleaves the third component of complement. 1974. Hoppe-Seyler's Z. Physiol. Chem. 355, 171-183.
14. C.-W. Vogel, and H. J. Müller-Eberhard: The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. 1982. J. Biol. Chem. 257, 8292-8299.
15. P. Hensley, M. C. O'Keefe, C. J. Spangler, J. C. Osborne, Jr., and C.-W. Vogel: The effects of metal ions and temperature on the interaction of cobra venom factor and human complement factor B. 1986. J. Biol. Chem. 261, 11038-11044.
16. I. Von Zabern, B. Hinsch, H. Przyklenk, H., G. Schmidt, and W. Vogt: Comparison of Naja n, naja and Naja h. haje cobra-venom factors: Correlation between binding affinity for the fifth component of complement and medication of its cleavage. 1980. Immunology 157, 499-514.
17. M. H. L. De Bruijn, and G. H. Fey: Human complement component C3: cDNA coding sequence and derived primary structure. 1985. Proc. Natl. Acad. Sci USA 82, 708-712.
18. J. Alsenz, D. Avila, H. P. Huemer, I. Esparza, J. D. Becherer, T. Kinoshita, Y. Wang, S. Oppermann, and J. D. Lambris, Phylogeny of the third component of complement C3: Analysis of the conservation of human CR1, CR2, H, and B binding sites, ConA binding sites, and thiolester bond in the C3 from different species. 1992. Dev. Comp. Immunol. 16, 63-76.
19. S. Hase, N. Kikuchi, T. Ikenaka, and K. Inoue. Structures of sugar chains of the third component of human complement. 1985. J. Biochem. 98, 863-874.
20. S. Hirani, J. D. Lambris, and H. J. Müller-Eberhard. Structural analysis of the asparagine-linked oligosaccharides of human complement component C3. 1986. Biochem. J. 233, 613-616.
21. K. Miki, S. Ogata, Y. Misumi, and Y. Ikehara. Carbohydrate structures of the third component of rat complement. 1986. Biochem. J. 240, 6991-698.
22. D. C. Fritzinger, R. Bredehorst, and C.-W. Vogel. Molecular cloning and derived primary structure of cobra venom factor. 1994. Proc. Natl. Acad. Sci. USA 91, 12775-12779.
23. S. B. Needleman, and C. D. Wunsch: A general method applicable to the search for similarities in the amino acid sequences of two proteins. 1970. J. Mol. Biol. 48, 443-453.
24. M. C. O'Keefe, L. H. Caporale, and C.-W. Vogel: A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor. 1988. J. Biol. Chem. 263, 12690-12697.
25. D. C. Fritzinger, K. C. Petrella, M. B. Connelly, R. Bredehorst, and C.-W. Vogel: Primary structure of cobra complement component C3, 1992. J. Immunol. 149, 3554-3562.
26. M. J. Selby, R. H. Edwards, and W. J. Rutter: Cobra nerve growth factor: Structure and evolutionary comparison. 1987. J. Neuroscience Res. 18, 293-298.
27. D. Neumann, D. Barchen, M. Horowitz, E. Kochva, and S. Fuchs: Snake acetylcholine receptor: Cloning of the domain containing the four extracellular cysteines of the alpha-subunit. 1989. Proc. Natl. Acad. Sci. USA 86, 7255-7259.
28. A. Lundwall, R. A. Wetsel, H. Domdey, B. F. Tack, and G. H. Fey: Structure of murine complement component C3: I. Nucleotide sequence of cloned complementary and genomic DNA coding for the β-chain. 1984. J. Biol. Chem. 259, 13851-13856.
29. R. A. Wetsel, Å. Lundwall, F. Davidson, T. Gibson, B. F. Tack, and G. H. Fey: Structure of murine complement component C3: II. Nucleotide sequence of cloned complementary DNA coding for the α-chain. 1984. J. Biol. Chem. 259, 13857-13862.
30. Y. Misumi, M. Sohda, and Y. Ikehara: Nucleotide and deduced amino acid sequence of rat complement C3. 1990. Nucleic Acids Res. 18, 2178.
31. H. S. Auerbach, R. Burger, A. Dodds, and H. R. Colten: Molecular basis of complement C3 deficiency in guinea pigs. 1990. J. Clin. Invest. 86, 96-106.
32. M. Kusano, N. H. Choi, M. Tomita, K.-I. Mamamoto, S. Migita, T. Sekiya, and S. Nishimura: Nucleotide sequence of cDNA and derived amino acid sequence of rabbit complement component C3 α-chain. 1986. Immunol. Inv. 15, 365-378.
33. D. Grossberger, A. Marcuz, L. Du Pasquier, and J. D. Lambris: Conservation of structural and functional domains in complement component C3 of Xenopus and mammals. 1989. Proc. Natl. Acad. Sci. USA 86, 1323-1327.
34. J. V. Maizel, Jr., and R. P. Lenk: Enhanced graphic matrix analysis of nucleic acid and protein sequences. 1981. Proc. Natl. Acad. Sci. USA 78, 7665-7669.
35. T. P. Hopp, and K. R. Woods: Prediction of protein antigenic determinants from amino acid sequences. 1981. Proc. Natl. Acad. Sci. USA 78, 3824-3828.
36. R. Huber, H. Scholze, E. P. Paques, and J. Deisenhofer. Crystal structure analysis and molecular model of human C3a anaphylatoxin. 1980 Hoppe-Seyler's Z. Physiol. Chem. 361, 1389-1399.
37. K. Dolmer, and L. Sottrup-Jensen: Disulfide bridges in human complement component C3b. 1993. FEBS Lett. 315, 85-90.
38. M. K. Pangburn: Spontaneous reformation of the intramolecular thioester in complement protein C3 and low temperature capture of a conformational intermediate capable of reformation. 1992. J. Biol. Chem. 267, 8584-8590.
39. M. E. Daoudaki, J. D. Becherer, and J. D. Lambris: A 34-amino acid peptide of the third component of complement mediates properdin binding. 1988. J. Immunol. 140, 1577-1580.
40. D. T. Fearon, and K. F. Austen: Properdin: Binding to C3b and stabilization of the C3b-dependent C3 convertase. 1975. J. Exp. Med. 142, 856-863.
41. C. G. Cochrane, H. J. Müller-Eberhard, and B. S. Aikin: Depletion of plasma complement in vivo by a protein of cobra venom: Its effects on various immunologic reactions. 1970. J. Immunol. 105, 55-69.
42. G. O. Till, K. J. Johnson, R. Kunkel, and P. A. Ward. Intravascular activation of complement and acute lung injury. 1982. J. Clin Invest. 69, 1126-1135.
43. C.-W. Vogel, and H. J. Müller-Eberhard: The cobra complement system: I. The alternative pathway of activation. 1985. Dev. Comp. Immunol. 9, 311-325.
44. C.-W. Vogel, and H. J. Müller-Eberhard: Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase. 1981. Proc. Natl. Acad Sci. USA 78, 7707-7711.
45. B. Müller, and W. Müller-Ruchholtz. Covalent conjugates of monoclonal antibody and cobra venom factor mediate specific cytotoxicity via alternative pathway of human complement activation. Leukemia Res. 11, 461-468.
46. 2-cobra venom factor conjugate are equally cytotoxic. 1990. Mol. Immunol. 27, 957-964.
47. J. R. Leventhal, A. P. Dalmasso, J. W. Cromwell, J. L. Platt, C. J. Manivel, R. M. Bolman III, and A. J. Matas: Prolongation of cardiac xenograft survival by depletion of complement. 1993. Transplantation 55, 857-866.